News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
212,652 Results
Type
Article (35452)
Company Profile (16)
Press Release (177184)
Section
Business (65237)
Career Advice (463)
Deals (6008)
Drug Delivery (26)
Drug Development (28734)
Employer Resources (52)
FDA (4666)
Job Trends (4526)
News (103405)
Policy (6959)
Tag
Academia (2442)
Africa (315)
Alliances (14313)
Alzheimer's disease (524)
Antibody-drug conjugate (ADC) (18)
Approvals (4660)
Arizona (38)
Artificial intelligence (20)
Asia (11796)
Australia (2970)
Bankruptcy (59)
Best Places to Work (3593)
Biosimilars (18)
C2C Services and Suppliers (19316)
California (436)
Canada (209)
Cancer (114)
Career advice (423)
CAR-T (24)
Cell therapy (41)
China (40)
Clinical research (21605)
Collaboration (24)
Colorado (26)
Connecticut (21)
COVID-19 (1400)
Cystic fibrosis (23)
Data (57)
Diagnostics (1955)
Diversity, equity & inclusion (18)
Drug pricing (29)
Earnings (10651)
Employer resources (46)
Europe (31881)
Events (23493)
Executive appointments (85)
FDA (4710)
Florida (60)
Funding (34)
Gene therapy (20)
GLP-1 (156)
Government (1282)
Healthcare (6292)
Hotbed/Location (129346)
Illinois (87)
Indiana (34)
Infectious disease (1405)
Inflammatory bowel disease (33)
Interviews (56)
IPO (2308)
IRA (20)
Job creations (943)
Job search strategy (397)
Layoffs (76)
Legal (1655)
Liver cancer (19)
Lung cancer (17)
Maryland (66)
Massachusetts (260)
Medical device (3940)
Medtech (3940)
Mergers & acquisitions (3664)
Metabolic disorders (50)
Michigan (27)
Minnesota (48)
Neuroscience (569)
New Hampshire (18)
New Jersey (127)
New York (144)
NextGen Class of 2024 (2293)
Non-profit (2072)
North Carolina (201)
Northern California (230)
Obesity (26)
Ohio (39)
Opinion (65)
Pennsylvania (114)
People (35257)
Phase I (6635)
Phase II (9535)
Phase III (7102)
Pipeline (27)
Policy (33)
Postmarket research (1204)
Preclinical (3301)
Press Release (27)
Rare diseases (32)
Real estate (1673)
Recruiting (22)
Regulatory (4288)
Research institute (1467)
Resumes & cover letters (33)
South America (358)
Southern California (180)
Startups (1462)
Texas (61)
United States (1986)
Vaccines (226)
Washington State (54)
Weight loss (23)
Date
Today (1)
Last 7 days (156)
Last 30 days (492)
Last 365 days (10442)
2024 (6707)
2023 (11749)
2022 (16321)
2021 (17370)
2020 (16739)
2019 (15659)
2018 (11731)
2017 (10944)
2016 (10895)
2015 (12686)
2014 (9432)
2013 (9056)
2012 (9101)
2011 (9180)
2010 (8312)
212,652 Results for "johns hopkins university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
Danaher Corporation, a global science and technology innovator, launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild TBI.
May 9, 2024
·
6 min read
Press Releases
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
TriLink BioTechnologies, a Maravai™ LifeSciences company and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery.
May 13, 2024
·
3 min read
BioCapital
Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University
Inhibitor Therapeutics, Inc. has entered into an exclusive, worldwide licensing agreement with Johns Hopkins University for their U.S Patent 8,980,930 “New Angiogenesis Inhibitors”.
December 13, 2023
·
5 min read
Biotech Beach
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
Exagen Inc., a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced the execution of an exclusive license agreement.
November 9, 2023
·
3 min read
Business
Allosteric Bioscience, Inc. Signs Sponsored Research Agreement with Dr. Susan Michaelis at Johns Hopkins University for Aging/Longevity-Related Work
Allosteric Bioscience, Inc. (ABI) has signed a Sponsored Research Agreement (SRA) with Dr. Susan Michaelis at Johns Hopkins University for analysis of chemical leads for modulation (increase or decrease) of key protein targets for Optimizing Aging and Longevity.
January 17, 2024
·
3 min read
Business
Unravel Biosciences and Pitt Hopkins Research Foundation Announce Collaboration to Conduct Clinical Study of RVL-001 in Pitt Hopkins Patients
Unravel Biosciences, Inc., (“Unravel”), an AI-enabled therapeutics company established to advance drugs for complex diseases, and the Pitt Hopkins Research Foundation (the “Foundation”) today announced a collaboration to conduct a proof of concept clinical trial of vorinostat (RVL-001) in patients with Pitt Hopkins Syndrome (PTHS).
June 11, 2024
·
3 min read
Business
Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University
Histogen Inc. (HSTO) today announced that the company has signed an exclusive license agreement with Johns Hopkins University.
April 3, 2023
·
6 min read
Business
Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder
Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”) is pleased to announce that the company has entered into a Clinical Trial Agreement with Johns Hopkins University School of Medicine (“JHU”) to conduct its Phase I/IIa clinical trial of its proprietary MEAI-based CMND-100 (“CMND-100”).
September 6, 2023
·
4 min read
BioMidwest
Panbela Announces New Research Agreement with Johns Hopkins University School of Medicine
Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced a new research agreement with the Johns Hopkins University School of Medicine.
April 3, 2023
·
6 min read
Drug Development
Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome
Neuren Pharmaceuticals announced top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome.
May 27, 2024
·
8 min read
1 of 21,266
Next